MD1003 (high doses of biotin) in progressive multiple sclerosis: subgroup analyses of the MS-SPI trial - Université de Rennes Access content directly
Journal Articles Multiple Sclerosis Journal Year : 2015

MD1003 (high doses of biotin) in progressive multiple sclerosis: subgroup analyses of the MS-SPI trial

Christine Lebrun-Frenay
M. Clanet
  • Function : Author
C. Papex
  • Function : Author
S. Vukusic
  • Function : Author
J. de Sesze
  • Function : Author
Marc Debouverie
  • Function : Author
  • PersonId : 762777
  • IdRef : 068986629
O. Gout
  • Function : Author
Pierre Clavelou
  • Function : Author
Gilles Defer
  • Function : Author
David A. Laplaud
  • Function : Author
  • PersonId : 976578
Thibault Moreau
  • Function : Author
Pierre Labauge
Bruno Brochet
F. Sedel
  • Function : Author
J Pelletier
  • Function : Author

Abstract

no abstract
No file

Dates and versions

hal-01259396 , version 1 (20-01-2016)

Identifiers

  • HAL Id : hal-01259396 , version 1

Cite

Ayman Tourbah, Christine Lebrun-Frenay, Gilles Edan, M. Clanet, C. Papex, et al.. MD1003 (high doses of biotin) in progressive multiple sclerosis: subgroup analyses of the MS-SPI trial. Multiple Sclerosis Journal, 2015, 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, OCT 07-10, 2015, 21 (11), pp.785. ⟨hal-01259396⟩
112 View
0 Download

Share

Gmail Facebook X LinkedIn More